Ultimately, we return to the study by Nakano et al.
(1) and the other studies noted previously that attempt to provide the clinician with a robust, accurate, easy-to-use, and easy-to-understand and interpret diagnostic tool that has a high positive and negative predictive value in the clinical setting and that does not require specific expertise or a core-lab analysis to determine whether a plaque is a TCFA and whether it should be treated preemptively: a yes/no, "red light"/"green light,"
"treat"/"don't treat" tool. OCT alone does not appear to be this tool. Perhaps combination imaging devices or technologies. Only time and only clinical studies will tell. KEY WORDS histology, integrated backscatter intravascular ultrasound, optical frequency domain imaging, thin-cap fibroatheroma, vulnerable plaque
